Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

2(40.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05036096Not ApplicableActive Not Recruiting

Cone Beam Breast CT for Breast Cancer Screening

Role: lead

NCT03354611Phase 2Terminated

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

Role: lead

NCT03861221Not ApplicableCompleted

The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast Cancer

Role: collaborator

NCT01750320Phase 1Completed

Koning Breast Computed Tomography Guided Biopsy

Role: lead

NCT02864667Completed

Reader Study for Image Quality of Cone Beam Breast CT System

Role: lead

NCT01771497Completed

Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring

Role: lead

NCT01952717Completed

PMA Required Pivotal Multi-reader Multi-case Reader Study

Role: lead

NCT01880580Completed

Cone Beam CT for Breast Imaging

Role: lead

NCT01107860Completed

Cone Beam Computed Tomography for Breast Imaging

Role: lead

NCT00972413Phase 1Completed

Cone Beam Computed Tomography for Breast Imaging

Role: lead

All 10 trials loaded